Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chih-lung Lin

Showing results (201-210 of 209) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 209 results.
Cytokine|December 25, 2012
Plasma levels of transforming growth factor-beta 1 before and after removal of low- and high-grade astrocytomasJoon-Khim Loh, Ann-Shung Lieu, Yu-Feng Su, et al.
Plos One|January 30, 2014
Elevated serum triglyceride and retinol-binding protein 4 levels associated with fructose-sweetened beverages in adolescentsTe-Fu Chan, Wei-Ting Lin, Yi-Ling Chen, et al.
The Kaohsiung Journal of Medical Sciences|May 30, 2008
Low-grade astrocytoma associated with abscess formation: case report and literature reviewTai-Hsin Tsai, Yan-Fen Hwang, Shiuh-Lin Hwang, et al.
Scientific Reports|April 11, 2017
Corrigendum: Protein tyrosine phosphatase 1B targets PITX1/p120RasGAP thus showing therapeutic potential in colorectal carcinomaHao-Wei Teng, Man-Hsin Hung, Li-Ju Chen, et al.
Scientific Reports|October 19, 2016
Protein tyrosine phosphatase 1B targets PITX1/p120RasGAP thus showing therapeutic potential in colorectal carcinomaHao-Wei Teng, Man-Hsin Hung, Li-Ju Chen, et al.
NPJ Vaccines|November 20, 2025
To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunizationEn-Shuo Liu, Kai-Wen Ho, Chin-Chung Wu, et al.
Plos One|March 4, 2014
A porphodimethene chemical inhibitor of uroporphyrinogen decarboxylaseKenneth W Yip, Zhan Zhang, Noriko Sakemura-Nakatsugawa, et al.
Investigative Ophthalmology & Visual Science|February 9, 2019
A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular HyperemiaCherng-Ru Hsu, Yi-Hsun Chen, Chih-Peng Liu, et al.
Bioorganic & Medicinal Chemistry Letters|September 14, 2010
Novel azulene-based derivatives as potent multi-receptor tyrosine kinase inhibitorsChih-Hung Chen, On Lee, Chung-Niang Yao, et al.
Pageof 21

Showing results (201-210 of 209) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 209 results.
Cytokine|December 25, 2012
Plasma levels of transforming growth factor-beta 1 before and after removal of low- and high-grade astrocytomasJoon-Khim Loh, Ann-Shung Lieu, Yu-Feng Su, et al.
Plos One|January 30, 2014
Elevated serum triglyceride and retinol-binding protein 4 levels associated with fructose-sweetened beverages in adolescentsTe-Fu Chan, Wei-Ting Lin, Yi-Ling Chen, et al.
The Kaohsiung Journal of Medical Sciences|May 30, 2008
Low-grade astrocytoma associated with abscess formation: case report and literature reviewTai-Hsin Tsai, Yan-Fen Hwang, Shiuh-Lin Hwang, et al.
Scientific Reports|April 11, 2017
Corrigendum: Protein tyrosine phosphatase 1B targets PITX1/p120RasGAP thus showing therapeutic potential in colorectal carcinomaHao-Wei Teng, Man-Hsin Hung, Li-Ju Chen, et al.
Scientific Reports|October 19, 2016
Protein tyrosine phosphatase 1B targets PITX1/p120RasGAP thus showing therapeutic potential in colorectal carcinomaHao-Wei Teng, Man-Hsin Hung, Li-Ju Chen, et al.
NPJ Vaccines|November 20, 2025
To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunizationEn-Shuo Liu, Kai-Wen Ho, Chin-Chung Wu, et al.
Plos One|March 4, 2014
A porphodimethene chemical inhibitor of uroporphyrinogen decarboxylaseKenneth W Yip, Zhan Zhang, Noriko Sakemura-Nakatsugawa, et al.
Investigative Ophthalmology & Visual Science|February 9, 2019
A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular HyperemiaCherng-Ru Hsu, Yi-Hsun Chen, Chih-Peng Liu, et al.
Bioorganic & Medicinal Chemistry Letters|September 14, 2010
Novel azulene-based derivatives as potent multi-receptor tyrosine kinase inhibitorsChih-Hung Chen, On Lee, Chung-Niang Yao, et al.
Pageof 21